Kyntra Bio, Inc. · NASDAQ:KYNB

Armistice Capital, LLC reported a 9.88% stake in Kyntra Bio, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Armistice Capital, LLC reported a 9.88% stake in Kyntra Bio, Inc., 400,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.88%
Shares
400,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC9.88%400,000
Steven Boyd9.88%400,000

Source

View original at SEC

Related